The digital biomarkers market is witnessing considerable growth owing to the increasing adoption of digital technologies in the healthcare sector. Digital biomarkers are measurable digital characteristics obtained from various digital sources such as mobile apps, wearable devices, and social media. They can help clinicians and researchers accurately quantify health and disease status, range of symptoms, and the effectiveness of treatment among patients.

The global digital biomarkers market size is estimated to be valued at US$ 3.3 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
The key opportunity driving the growth of the digital biomarkers market is its ability to improve patient outcomes. Digital biomarkers offer real-time, continuous data on patient health status and treatment effectiveness which helps physicians make more informed treatment decisions. This results in better clinical management leading to improved patient outcomes. Data from digital biomarkers also help pharmaceutical companies design more effective clinical trials and develop targeted drug therapies. Continuous monitoring through digital biomarkers ensures medication adherence and early detection of adverse effects which positively impacts treatment success rates. Therefore, the ability of digital biomarkers to enhance clinical decision making and patient care through continuous health monitoring is expected to significantly fuel the demand over the forecast period.

Porter’s Analysis

Threat of new entrants: The threat of new entrants is moderately high as the digital biomarkers market requires significant R&D investments and regulatory approvals. However, several small and medium enterprises are entering this space by developing niche solutions.

Bargaining power of buyers: The bargaining power of buyers is moderate given the growing demand for digital biomarkers. However, the availability of alternative treatment options somewhat limits buyer power.

Bargaining power of suppliers: Digital biomarkers rely on technologies such as biosensors, apps, and AI/ML platforms. The availability of such solutions provides suppliers with moderate bargaining power.

Threat of new substitutes: There is a risk of substitutes as novel AI/ML and sensing methods can disrupt existing digital biomarkers. However, the market recognizes few direct substitutes currently.

Competitive rivalry: The competitive rivalry is high given the presence of several global players offering a varied portfolio of digital biomarkers. Partnerships and M&As remain common to enhance offerings.

SWOT Analysis

Strengths: Non-invasive nature and ability to enable continuous remote monitoring. Growing expertise in AI/ML analytics.

Weaknesses: Concerns around data privacy and regulatory approvals. Limited clinical validity of some markers.

Opportunities: Rising incidence of chronic diseases. Growing adoption of digital health solutions post-COVID.

Threats: Reimbursement and insurance coverage challenges. Emerging alternative monitoring methods.

Key Takeaways

The global Digital Biomarkers market is expected to witness high growth over the forecast period of 2024 to 2031. Global Digital Biomarkers Market Size for 2024 is estimated to be US$ 3.3 Bn and projected to reach over US$ 10 Bn by 2031, exhibiting a CAGR of around 8%.

Regional analysis indicates North America currently dominates the market owing to early technology adoption and supportive regulatory environment. Asia Pacific is poised to grow at the fastest pace led by countries like China and India expanding their digital healthcare infrastructure.

Key players operating in the Digital Biomarkers market are Purina Mills LLC, Nutreco N.V., Roquette Freres S.A., Evonik Industries A G, Charoen Pokphand Foods PLC, Alltech Inc., Associated British Foods Plc., Koninklijke DSM NV, BASF SE, ACI Godrej Agrovet Private Limited. Major players are focusing on partnerships and M&As to enhance their digital biomarkers offerings.

Get More Insights on this Topic- https://www.dailyprbulletin.com/digital-biomarkers-market-growth-value-and-analysis/